Search by Drug Name or NDC

    NDC 00409-9045-17 Bupivacaine Hydrochloride and Epinephrine 5; 5 mg/mL; ug/mL Details

    Bupivacaine Hydrochloride and Epinephrine 5; 5 mg/mL; ug/mL

    Bupivacaine Hydrochloride and Epinephrine is a EPIDURAL; INTRACAUDAL; PERINEURAL INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE.

    Product Information

    NDC 00409-9045
    Product ID 0409-9045_832b49a9-8fed-4b1b-bf60-c330520ef46a
    Associated GPIs 69991002102017
    GCN Sequence Number 052188
    GCN Sequence Number Description bupivacaine HCl/epinephrine/PF VIAL 0.5-1:200K INJECTION
    HIC3 H0A
    HIC3 Description LOCAL ANESTHETICS
    GCN 19752
    HICL Sequence Number 025242
    HICL Sequence Number Description BUPIVACAINE HCL/EPINEPHRINE/PF
    Brand/Generic Generic
    Proprietary Name Bupivacaine Hydrochloride and Epinephrine
    Proprietary Name Suffix n/a
    Non-Proprietary Name BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, SOLUTION
    Route EPIDURAL; INTRACAUDAL; PERINEURAL
    Active Ingredient Strength 5; 5
    Active Ingredient Units mg/mL; ug/mL
    Substance Name BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE BITARTRATE
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Amide Local Anesthetic [EPC], Amides [CS], Catecholamine [EPC], Catecholamines [CS], Local Anesthesia [PE], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA071168
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-9045-17 (00409904517)

    NDC Package Code 0409-9045-17
    Billing NDC 00409904517
    Package 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-9045-17) / 30 mL in 1 VIAL, SINGLE-DOSE (0409-9045-16)
    Marketing Start Date 2011-03-21
    NDC Exclude Flag N
    Pricing Information N/A